About Cryo-Cell
Investor Relations
A healthy investment in healthier futures.
Cryo-Cell has been a publicly traded company since 1991. Governed by the Securities & Exchange Commission, our common stock trades under the OTC Bulletin Board symbol CCEL. We specialize in U-Cord® stem cell preservation for family use.
Press Releases
10/26/2009
Cryo-Cell International Recognized by Tampa Bay Technology Forum
10/15/2009
Cryo-Cell Announces C`elle SM Technology Licence Agreement with Cryopraxis Cryobiology Ltd.
10/13/2009
Cryo-Cell International, Inc. Reports Third Quarter 2009 Results and Safti-Cell, Inc. Transaction
10/6/2009
Cryo-Cell International`s Stem Cell Research and Development Helps the Fight Against Breast Cancer
10/1/2009
Cryo-Cell Expands Strategic Partnership with S-Evans Biosciences, Inc.
9/29/2009
9/9/2009
Cryo-Cell International, Inc. to Present At The Rodman & Renshaw, LLC Conference
8/12/2009
Cryo-Cell Announces Strategic Partnership With S-Evans Biosciences, Inc.
Read more articles in the Archive
Financial Highlights
Section 16 Filings: All Insiders
Annual Reports
Quarterly & Other Reports
Stock Quote
Fundamentals
News
Chart
Real-Time Filings
Webcasts
Featured in
Upromise.com: helping you save for your children’s education through family blood banking (only with Cryo-Cell).
Partners
Wake Forest University | Duke University | Stanford University | University of South Florida | American College of Obstetricians & Gynecologists | American College of Nurses & Midwives | Florida Blood Services | National Hispanic Medical Association | Google | Yahoo | Cryo-Cell Latin America & Asia | Babyzone.com
As seen on
Facebook
TwitterBookmark this
Copyright © 2008 Cryo-Cell International, Inc. All Rights Reserved. Privacy Policy | Site Map
Web Design & Digital Marketing Solutions provided by Horizon Marketing Group, Inc.